KPNA3 promotes epithelial-mesenchymal transition by regulating TGF-β and AKT signaling pathways in MDA-MB-231 a triple-negative breast cancer cell line

被引:2
作者
Choi, Jaesung [1 ]
Choi, Jee-Hye [1 ]
Lee, Ho Woon [1 ]
Seo, Dongbeom [1 ]
Lkhagvasuren, Gavaachimed [2 ]
Kim, Jung-Woong [1 ]
Seo, Sang-Beom [1 ]
Lee, Kangseok [1 ]
Lee, Kwang-Ho [1 ,2 ]
机构
[1] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul 06974, South Korea
[2] Chung Ang Univ, Grad Sch, Dept Sci Cultural Heritage, Seoul 06974, South Korea
关键词
Epithelial-mesenchymal transition; GATA3; HAS2; KPNA3; Triple-negative breast cancer;
D O I
10.5483/BMBRep.2022-0180
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Karyopherin-alpha 3 (KPNA3), a karyopherin-alpha isoform, is intimately associated with metastatic progression via epithelial-mesen-chymal transition (EMT). However, the molecular mechanism underlying how KPNA3 acts as an EMT inducer remains to be elucidated. In this report, we identified that KPNA3 was significantly upregulated in cancer cells, particularly in triple-negative breast cancer, and its knockdown resulted in the suppression of cell proliferation and metastasis. The comprehensive transcriptome analysis from KPNA3 knockdown cells indicated that KPNA3 is involved in the regulation of numerous EMT-related genes, including the downregulation of GATA3 and E-cadherin and the up-regulation of HAS2. Moreover, it was found that KPNA3 EMT-mediated metastasis can be achieved by TGF-beta or AKT signaling pathways; this suggests that the novel independent signaling pathways KPNA3-TGF-beta-GATA3-HAS2/E-cadherin and KPNA3-AKT-HAS2/E-cadherin are involved in the EMT-mediated progress of TNBC MDA-MB-231 cells. These findings provide new insights into the divergent EMT inducibility of KPNA3 according to cell and cancer type.
引用
收藏
页码:120 / 125
页数:6
相关论文
共 22 条
[1]   EMT: 2016 [J].
Angela Nieto, M. ;
Huang, Ruby Yun-Ju ;
Jackson, Rebecca A. ;
Thiery, Jean Paul .
CELL, 2016, 166 (01) :21-45
[2]   Eupatolide inhibits the TGF-β1-induced migration of breast cancer cells via downregulation of SMAD3 phosphorylation and transcriptional repression of ALK5 [J].
Boldbaatar, Ariundavaa ;
Lee, Sunyi ;
Han, Sora ;
Jeong, Ae Lee ;
Ka, Hye In ;
Buyanravjikh, Sumiyasuren ;
Lee, Jeong Hyung ;
Lim, Jong-Seok ;
Lee, Myung Sok ;
Yang, Young .
ONCOLOGY LETTERS, 2017, 14 (05) :6031-6039
[3]   Revisiting the hallmarks of cancer: The role of hyaluronan [J].
Caon, Ilaria ;
Bartolini, Barbara ;
Parnigoni, Arianna ;
Carava, Elena ;
Moretto, Paola ;
Viola, Manuela ;
Karousou, Evgenia ;
Vigetti, Davide ;
Passi, Alberto .
SEMINARS IN CANCER BIOLOGY, 2020, 62 :9-19
[4]   Structure of importin-β bound to tbe IBB domain of importin-α [J].
Cingolani, G ;
Petosa, C ;
Weis, K ;
Müller, CW .
NATURE, 1999, 399 (6733) :221-229
[5]   Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping [J].
Dai, Xiaofeng ;
Cheng, Hongye ;
Bai, Zhonghu ;
Li, Jia .
JOURNAL OF CANCER, 2017, 8 (16) :3131-3141
[6]   Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases [J].
Geervliet, Eline ;
Bansal, Ruchi .
CELLS, 2020, 9 (05)
[7]   Neuropilin-1 as therapeutic target for malignant melanoma [J].
Graziani, Grazia ;
Lacal, Pedro M. .
FRONTIERS IN ONCOLOGY, 2015, 5
[8]   Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer Progression [J].
Groeger, Christian J. ;
Grubinger, Markus ;
Waldhoer, Thomas ;
Vierlinger, Klemens ;
Mikulits, Wolfgang .
PLOS ONE, 2012, 7 (12)
[9]  
Heath VL, 2000, EUR J IMMUNOL, V30, P2639, DOI 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO
[10]  
2-7